Actively Recruiting
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
Led by Sir Run Run Shaw Hospital · Updated on 2026-03-02
100
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
Sponsors
S
Sir Run Run Shaw Hospital
Lead Sponsor
Q
Quzhou Third hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is a double-blind, randomized, controlled intervention study aimed at exploring whether high-frequency transcranial alternating current stimulation (Hi-tACS) can improve cognitive impairment in patients with schizophrenia.
CONDITIONS
Official Title
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meets the diagnostic criteria for schizophrenia according to DSM-5.
- Age 18 years old.
- Right-handed.
- Willing to participate and sign an informed consent form, or have a legal guardian sign if unable.
- Clinically stable and on a stable dose of antipsychotic medication for at least 4 weeks.
- Montreal Cognitive Assessment score 10 points.
You will not qualify if you...
- Psychotic disorders caused by split affective disorder, bipolar disorder, intellectual disability, anxiety spectrum disorders, drugs, alcohol, or other psychoactive substances.
- Severe or unstable organic diseases, history of brain tumors or epilepsy.
- Received MECT or TMS treatment within 1 month before enrollment.
- Compromised skin integrity at electrode placement sites or allergy to electrode gel or adhesive.
- Implants of metal or electronic devices such as pacemakers, cochlear implants, deep brain stimulators, aneurysm clips, or internal fixation devices.
- Participation in any other clinical trials within 1 month prior to baseline.
- Pregnant or breastfeeding women.
- Investigator believes participation is inappropriate.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Sir Run Run Shaw Hospital
Hanzhou, Zhejiang, China, 310020
Actively Recruiting
2
Quzhou Third Hospital
Quzhou, Zhejiang, China, 324003
Actively Recruiting
Research Team
J
Jinsong Tang, Doctorate
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here